Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells

Zhi Jie Hou, Xi Luo, Wei Zhang, Fei Peng, Bai Cui, Si Jin Wu, Fei Meng Zheng, Jie Xu, Ling Zhi Xu, Zi Jie Long, Xue Ting Wang, Guo Hui Li, Xian Yao Wan, Yong Liang Yang, Quentin Liu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

75 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science